Finoriq research workspace
Alamar Biosciences, Inc. (ALMR) SEC Filings & Filing Highlights
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform. Review ALMR SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company's offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. The company was incorporated in 2018 and is based in Fremont, California.
- Company
- Alamar Biosciences, Inc. (ALMR)
- Ticker
- ALMR
- Market Cap
- $1.7B
- Latest Price
- $24.08
- Industry
- Life Science Tools
Alamar Biosciences, Inc. (ALMR) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Alamar Biosciences, Inc. (ALMR).
| Event | Form | Date |
|---|---|---|
| Alamar Biosciences Reports First Quarter 2026 Financial ResultsAlamar Biosciences Reports First Quarter 2026 Financial Results | 8-K2.02 | 2026-05-08 |
| Alamar Biosciences, Inc.: Corporate updateOn April 20, 2026, the Company completed its IPO of an aggregate of 12,937,500 shares of common stock (which includes the exercise in full... | 8-K8.01 | 2026-04-20 |
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K5.03 | 2026-04-20 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.